Genmab
GMAB
#1370
Rank
C$18.81 B
Marketcap
$28.50
Share price
-0.79%
Change (1 day)
-31.07%
Change (1 year)

Genmab (GMAB) - Cash on Hand

Cash on Hand as of September 2024 : C$3.69 Billion

According to Genmab's latest financial reports the company has C$3.69 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genmab - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$5.52 B26.69%
2022-12-31C$4.36 B16.26%
2021-12-31C$3.75 B10.72%
2020-12-31C$3.38 B57.74%
2019-12-31C$2.14 B68.58%
2018-12-31C$1.27 B15.95%
2017-12-31C$1.09 B47.28%
2016-12-31C$0.74 B5.09%
2015-12-31C$0.71 B40.82%
2014-12-31C$0.50 B64.33%
2013-12-31C$0.30 B15.73%
2012-12-31C$0.26 B35.95%
2011-12-31C$0.19 B-33.71%
2010-12-31C$0.29 B13.61%
2009-12-31C$0.25 B-35.63%
2008-12-31C$0.40 B1464.05%
2007-12-31C$25.72 M-92.77%
2006-12-31C$0.35 B54.13%
2005-12-31C$0.23 B151.76%
2004-12-31C$91.73 M35.36%
2003-12-31C$67.77 M19.75%
2002-12-31C$56.59 M